These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36535831)

  • 21. Whole-Body Voxel-Based Personalized Dosimetry: The Multiple Voxel S-Value Approach for Heterogeneous Media with Nonuniform Activity Distributions.
    Lee MS; Kim JH; Paeng JC; Kang KW; Jeong JM; Lee DS; Lee JS
    J Nucl Med; 2018 Jul; 59(7):1133-1139. PubMed ID: 29242397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of perfused volume segmentation between cone-beam CT and
    Martin M; Hocquelet A; Debordeaux F; Bordenave L; Blanc JF; Papadopoulos P; Lapuyade B; Trillaud H; Pinaquy JB
    Diagn Interv Imaging; 2021 Jan; 102(1):45-52. PubMed ID: 33032960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
    Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR
    J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the net administered activity in
    Henry EC; Lopez B; Mahvash A; Thomas MA; Kappadath SC
    Med Phys; 2023 Nov; 50(11):7003-7015. PubMed ID: 37272198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET-CT post therapy dosimetry in radioembolization with resin
    Richetta E; Pasquino M; Poli M; Cutaia C; Valero C; Tabone M; Paradisi BP; Pacilio M; Pellerito RE; Stasi M
    Phys Med; 2019 Aug; 64():16-23. PubMed ID: 31515015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
    Garin E; Rolland Y; Edeline J; Icard N; Lenoir L; Laffont S; Mesbah H; Breton M; Sulpice L; Boudjema K; Rohou T; Raoul JL; Clement B; Boucher E
    J Nucl Med; 2015 Mar; 56(3):339-46. PubMed ID: 25678490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.
    Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS
    J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of methods for in vivo activity and absorbed dose quantification with PET/CT following yttrium-90 radioembolization.
    Henry EC; Mahvash A; Lopez BP; Kappadath SC
    Med Phys; 2024 Sep; 51(9):6034-6045. PubMed ID: 38772046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of missing attenuation and scatter corrections on
    Botta F; Ferrari M; Chiesa C; Vitali S; Guerriero F; Nile MC; Mira M; Lorenzon L; Pacilio M; Cremonesi M
    Med Phys; 2018 Apr; 45(4):1684-1698. PubMed ID: 29383733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor Dose Response in Yttrium-90 Resin Microsphere Embolization for Neuroendocrine Liver Metastases: A Tumor-Specific Analysis with Dose Estimation Using SPECT-CT.
    Chansanti O; Jahangiri Y; Matsui Y; Adachi A; Geeratikun Y; Kaufman JA; Kolbeck KJ; Stevens JS; Farsad K
    J Vasc Interv Radiol; 2017 Nov; 28(11):1528-1535. PubMed ID: 28888827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monte Carlo
    Auditore L; Amato E; Boughdad S; Meyer M; Testart N; Cicone F; Beigelman-Aubry C; Prior JO; Schaefer N; Gnesin S
    Phys Med Biol; 2020 Nov; 65(23):235014. PubMed ID: 33245055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accurate non-tumoral 99mTc-MAA absorbed dose prediction to plan optimized activities in liver radioembolization using resin microspheres.
    d'Abadie P; Walrand S; Hesse M; Amini N; Lhommel R; Sawadogo K; Jamar F
    Phys Med; 2021 Sep; 89():250-257. PubMed ID: 34438353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The superior predictive value of
    Smits MLJ; Dassen MG; Prince JF; Braat AJAT; Beijst C; Bruijnen RCG; de Jong HWAM; Lam MGEH
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):798-806. PubMed ID: 31399801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioembolization lung shunt estimation based on a
    Kunnen B; van der Velden S; Bastiaannet R; Lam MGEH; Viergever MA; de Jong HWAM
    Med Phys; 2018 Oct; 45(10):4744-4753. PubMed ID: 30179259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetry of Y-90 Microspheres Utilizing Tc-99m SPECT and Y-90 PET.
    Tafti BA; Padia SA
    Semin Nucl Med; 2019 May; 49(3):211-217. PubMed ID: 30954187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
    Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
    J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
    Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
    J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative comparison of pre-therapy
    Knešaurek K; Tuli A; Pasik SD; Heiba S; Kostakoglu L
    Eur J Radiol; 2018 Dec; 109():57-61. PubMed ID: 30527312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of
    Balagopal A; Kappadath SC
    Med Phys; 2018 Feb; 45(2):875-883. PubMed ID: 29172243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.